SAB Biotherapeutics, Inc.
Nasdaq · Biological Products, (No Diagnostic Substances) · Miami Beach, FL
SABSW chart
What traders are saying about $SABSW
Latest postsSAB Biotherapeutics, Inc. news
- SAB Biotherapeutics, Inc. Estimates – NASDAQ:SABS
TradingView ·
- SAB Biotherapeutics Highlights Diabetes Trial Progress, Human Antibody Platform
marketbeat.com ·
- SAB BIO to Participate in Chardan 10th Annual Healthcare Conference
Yahoo Finance ·
- SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 Diabetes
Yahoo Finance ·
- SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress
Yahoo Finance ·
- SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes
Yahoo Finance ·
- SAB BIO to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- SAB Biotherapeutics Q2 Earnings Call Highlights
marketbeat.com ·
- SAB Biotherapeutics Inc (SABS) (Q2 2026) Earnings Call Highlights: Advancing SAB142 with Strong ...
Yahoo Finance ·
- SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights
Yahoo Finance ·
- SAB BIO to Host Second Quarter 2026 Financial Results Conference Call and Webcast on August 6, 2026, 08:30 AM ET
Yahoo Finance ·
- SAB Biotherapeutics (SABS) and Breakthrough T1D Award Research Grant For SAB-142 Assessment
Yahoo Finance ·
SAB Biotherapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $1.3M | $2.2M | $23.9M |
| Net income | $13.3M | -$34.1M | -$42.2M | -$18.7M |
| Diluted EPS | $-0.79 | $-3.68 | $-7.64 | $-4.31 |
| Total assets (year end) | $172.8M | $44.2M | $83.9M | $50.9M |
| Cash and equivalents (year end) | $10.5M | $8.9M | $56.6M | $15.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About SAB Biotherapeutics, Inc.
- Ticker
- SABSW (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Miami Beach, FL
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1833214
- Former names
- Big Cypress Acquisition Corp.
Frequently asked questions
What exchange is SAB Biotherapeutics, Inc. listed on?
SAB Biotherapeutics, Inc. trades on the Nasdaq under the ticker symbol SABSW.
What industry is SAB Biotherapeutics, Inc. in?
SAB Biotherapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)".
Where is SAB Biotherapeutics, Inc. headquartered?
SAB Biotherapeutics, Inc.'s business address on file with the SEC is in Miami Beach, FL.
When does SAB Biotherapeutics, Inc.'s fiscal year end?
SAB Biotherapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did SAB Biotherapeutics, Inc. report?
SAB Biotherapeutics, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.